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Abstract 
Background: Human gallbladder cancer (GBC) is an aggressive malignant neoplasm with a poor prognosis. The 
development of ideal tools for example tumor cell lines for investigating biological behavior, metastatic mechanism 
and potential treatment in GBCs is essential. In present study, we established and characterized a GBC cell line derived 
from primary tumor.
Methods: Primary culture method was used to establish this cell line from a primary GBC. Light and electron 
microscopes, flow cytometry, chromosome analysis, heterotransplantation and immunohistochemistry were used to 
characterize the epidemic tumor characteristics and phenotypes of this cell line.
Results: A novel GBC cell line, named TJ‑GBC2, was successfully established from primary GBC. This cell line had 
characteristic epithelial tumor morphology and phenotypes in consistent with primary GBC, such as polygon and 
irregular cell shape, increased CA19‑9 and AFP levels, and positive expression of CK7, CK8, CK19 and E‑cadherin with 
negative vimentin. Moreover, about 25% of the cells were in the S‑G2/M phase; abnormity in structure and number of 
chromosome with a peak number of 90–105 and 80% hypertetraploid were observed. Furthermore, this cell line had 
higher invasion and highest migration abilities compared to other GBC cell lines; and metastatic‑related marker MMP9 
and nm23 were positively expressed.
Conclusions: A novel highly aggressive GBC cell line TJ‑GBC2 was successfully established from primary GBC. 
TJ‑GBC2 cell line may be efficient tool for further investigating the biological behaviors, metastatic mechanism and 
potential targeted therapy of human GBC.
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Background
Human gallbladder cancer (GBC) is the most common 
malignancy of the biliary tract and the leading cause of 
cancer-related deaths in China, and is a lethal aggres-
sive malignant neoplasm with special malignant biologi-
cal characteristics, high early local invasion, extensive 
liver and lymph node metastases, low surgical resection 
rate (about 10% of GBC patients have a chance to receive 
surgery in the early stage), high postoperative recurrence 
rate, less sensitive to chemoradiotherapy, and unfavora-
ble survival [1–3]. Despite imaging technology progress 
in improving early diagnosis in GBC, prognosis of the 
patients, who received surgery, chemotherapy and/or 
radiotherapy, is still not satisfactory [1–4]. Therefore, fur-
ther studying the special biological behaviors, metastatic 
and recurrent mechanisms, and potential interventions 
of GBCs is of special significant, and remain challeng-
ing [5–7]; and novel GBC cell lines as ideal study models 
in vitro and in vivo are urgently developed. However, the 
establishment of highly aggressive GBC cell lines derived 
from primary tumor is very few and not thoroughly elu-
cidated [8–24]. In present study, we established a novel 
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highly aggressive GBC cell line derived from primary 
GBC, TJ-GBC2, which may prove to be an efficient tool 
for further investigation of the metastatic mechanism 
and potential treatment of this malignant disease.
Methods
Original tumor
This study was carried out in accordance with the Dec-
laration of Helsinki and the official recommendations of 
Chinese Community Guidelines, and was approved by 
the Ethics Committee and the Institutional Review Board 
at the Tongji Hospital. Written informed consent was 
obtained from this patient and his relation.
A 67-year-old Chinese man with symptoms of acute 
cholecystitis was referred to our hospital. High lev-
els of CA19-9 (>1000 U/ml), CA242 (58.4 U/ml), CA50 
(428.4 U/ml) and CEA (7.8 ng/ml) were detected in the 
patient’s serum by radioimmunoassay, whereas serum 
AFP showed in a normal range. Abdominal CT revealed 
a thickened, irregular gallbladder wall (1.5  cm) with 
involvement of the liver bed (6.0  cm) and hepatic bile 
duct dilatation. A radical GBC resection with partial 
hepatectomy was done. The postoperative pathological 
examination of the en bloc resected specimen showed 
that the GBC represented a poor differentiated adenocar-
cinoma forming nest-streak like arranged structures with 
atypical hyperplasia and caryokinesis, and most cells 
were of mucous epidermoid carcinoma differentiation 
(Fig. 1). The patient died about seven and a half months 
after operation with tumor recurrence, liver and extra-
hepatic bile duct metastases, and jaundice and hepatic 
failure.
Primary culture in vitro
The cell line was established from a primary tumor, 
which was surgically obtained from above GBC patient. 
After rinsing thrice with sterile PBS containing antibi-
otics, the tumor was minced into small fragment hav-
ing a diameter of 1 mm using a scalpel, and completely 
eliminated subcutaneous fat and submucosa. The frag-
ment was rinsed with PBS for 3 min, wet with 20% FBS 
(Corning, USA), then seeded into 25  ml culture bottle 
(Costar, USA). And, the culture bottle was inversionally 
incubated in a humidified incubator (SANYO, Japan) at 
37  °C in a 5% CO2 atmosphere for 4 h, then was put in 
normal direction, and added 3–4 ml DMEM/F12 (Gibco, 
USA) containing 20% FBS and 100 U/ml antibiotics along 
the edge of culture bottle slowly. After 5-day incubating, 
a small amount of cells climbing out around the tissue 
fragment, and a large number of lymphocytes and other 
miscellaneous cells were observed. The growth medium 
was renewed and replaced every 3 days, and the bottles 
were regularly checked for epithelial cells and fibroblast 
outgrowth. If fibroblast growth was observed during 
primary cultures, differential trypsinisation was used to 
obtain a pure tumor-cell population. After 5–6 passages 
tumor cells were basically purified. The cell line was cul-
tured for >60 passages.
Heterotransplantation in vivo
This study was carried out in accordance with ARRIVE 
(Animal Research: Reporting of In  Vivo Experiments) 
guidelines [25], and was approved by the Ethics Com-
mittee of Animal Experiments and the Institutional 
Review Board at the Tongji Hospital. TJ-GBC2 cells 
at the passage 35 were used to determine their tumo-
rigenicity in nude mice. The cultured cells (1 ×  107/ml) 
were harvested, washed, suspended in 0.1  ml of PBS, 
were then injected subcutaneously into the right flanks 
of 4-week-old athymic female nude mice (Balb/c-nu; 
Shanghai Silaike). Animals were examined every week 
for the development of tumors. Tumor-bearing mice 
were sacrificed. And, tumor tissue was excised, fixed in 
10% formalin, and processed for histopathology and 
immunohistochemistry.
Morphologic observation in vitro and in vivo
Morphologic observation included morphologic struc-
ture and ultrastructure of TJ-GBC2 cells in  vitro and 
morphologic structure of the xenograft of TJ-GBC2 cell 
lines in nude mice in vivo. For microscopy, the cultured 
TJ-GBC2 cells were photographed directly without stain-
ing, and histomorphologic structure of the xenograft 
in  vivo was observed with H&E staining under a phase 
contrast microscope (Caikang XDS-100, Shanghai, 
China). For electron microscopy, the monolayer cells cul-
tured in the flasks were fixed with 2.5% glutaraldehyde 
in 1  ml PBS (pH7.2), and post-fixed in a solution of 1% 
osmium tetraoxide. After dehydration in graded ethanol, 
the samples were then embedded in Epon resin. Ultrathin 
sections were stained with 2.3% uranyl acetate and lead 
citrate, and examined under a TEM (Jeol-1230) or SEM 
(Hitachi S-3400 N, Japan).
Cell proliferation, cell cycle assays and chromosome 
analysis in vitro
Cultured TJ-GBC2 cells (experimental group) and 
SGC996 cells derived from another primary GBC (con-
trol group) were used in this experiment. Cells were 
grown in a 96-well plate (5  ×  104 cells/100  μl/well) in 
DMEM/F12 medium with 10% FBS. The cell numbers 
were measured by a MTT assay according to the protocol 
provided by the MTT manufacturer. The doubling times 
were determined from the growth curve.
Cell cycle analysis was performed using a FCM (FlowJo 
software). Cells (1 × 106) in an exponential growth phase 
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were harvested and fixed with cold 70% alcohol after 
rinsing with cold PBS twice, incubated at 4  °C environ-
ment for 24  h. After being centrifuged at 1000  r/min 
for 5 min, the cells were rinsed with cold PBS once, sus-
pended in 500 μl PBS with 5 μl RNAase (10 mg/ml; Inv-
itrogen, USA) and incubated at 37  °C for 30  min, then 
stained with 5 μl propidium iodide (5 mg/ml; Invitrogen). 
This cell cycle analysis was performed in triplicate.
Chromosome analysis was performed for cells at the 
passage 50–54. Cells in an exponential growth phase 
were karyotyped using a standard air-dried method 
after treatment with a final concentration of 0.01 μg/ml 
colcemid for 2  h. A total of 50 metaphase spreads were 
counted to determine the modal number.
Invasion and migration assays in vitro
Five human GBC cell lines including TJ-GBC2, GBC-SD, 
NOZ, OCUG-1 and SGC996 were used to evaluate the 
migration and invasive abilities of GBC cells. TJ-GBC2 
cell line were maintained in DMEM/F12 supplemented 
with 10–20% FBS; GBC-SD (Type Culture Collection of 
the Chinese Academy of Sciences, Shanghai, China) and 
NOZ (gifted from Professor Liu YB) cell lines were main-
tained in DMEM (Corning, USA) supplemented with 
10% FBS; whereas the OCUG-1 (gifted from Professor 
Liu YB) and SGC-996 (Laboratory of Tumor Cytology, 
Tongji University School of Medicine, Shanghai, China) 
cell lines were maintained in RPMI-1640 medium (Gibco, 
USA) supplemented with 10% FBS, respectively.
Cell invasion in  vitro was assessed using the Tran-
swell chambers (Corning, USA). 200 μl cell suspensions 
(5  ×  104/well) were seeded onto the upper chamber, 
600 μl fresh growth medium with 10% FBS were placed 
into the lower chamber. After 24-h in a humidified incu-
bator at 37  °C with 5% CO2, cells that invaded through 
the basement membrane were stained with Giemsa 
(Sigma, USA), and counted under an inverted light 
microscope (Caikang XDS-100) in 5 independent fields 
Fig. 1 Epithelial tumor morphological characteristics of TJ‑GBC2 cell line. a Morphology of TJ‑GBC2 cell lines (at the passage 35–50) under a 
light microscopy (a1 × 100, a2 × 200). Cells grew mainly in clusters of polygonal cells, partially fusiform, spindly or irregular shape as an adherent 
monolayer sheet with characteristic epithelial cell morphology, in addition to big nucleoplasm ratio and multiple nucleoli. b Karyomegaly, dicaryon, 
clear cellular organelle structures such as ribosomes, mitochondria, prosperous endoplasmic reticulum, Golgi apparatus and secretory granules in 
cytoplasm, and lots of microvilli outside the network and cell connection were clearly observed under a transmission electron microscopy (TEM; 
b1–b3, × 10,000). c The divided cell and its surface full of densely filamentous microvilli and lamellar prominences were clearly visualized under a 
scanning electron microscopy (SEM; c1 × 2500, c2 × 7500, c3 × 4500). d The xenograft of TJ‑GBC2 cells in nude mice in vivo presented typical GBC 
features in nest‑streak like arrangement with atypical hyperplasia, caryokinesis and poor differentiation e.g. most of mucous epidermoid carcinoma 
differentiation, which were consistent with primary tumor of GBC
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at  ×200 magnification. Three independent experiments 
were performed.
Cell migration in vitro was determined using a wound-
healing assay. 200  μl cell suspensions (5  ×  105/well) 
were seeded in a 96-well plate (VP scientific, USA) for 
24  h. When cultured cells reached 50% confluence in a 
single layer, a wound was scratched at the center of the 
cell monolayer using a sterile scratch tester. Then, cells 
were washed with sterile PBS to remove floating cellu-
lar debris, and added with growth medium with FBS for 
24 h. The cell migrating area was scanned and analyzed 
at 0 h, 8 h and 24 h using a Cellomocs (Thermo, USA), 
and was observed under an inverted light microscope 
(Caikang XDS-100) at ×  50 magnifications. Cell migra-
tion area (pixel area) = (S3 + S4) − (S1 + S2). All experi-
ments were performed in triplicate.
Epithelial tumor marker and metastatic marker assays 
in vitro and in vivo
Epithelial tumor markers including CEA, CA19-9 and 
AFP in the supernatant from the cell culture were 
detected using an electrochemistry luminescence immu-
nity analyzer (Cobas E601, Roche, USA). The cultured 
cells (1 × 105) were collected and centrifuged at 1000 r/
min for 5  min. The supernatant was collected for CEA, 
CA19-9 and AFP. Pure growth medium was selected for 
a negative control.
Epithelial markers including CK7, CK8, CK19 and 
E-cadherin, and mesenchymal marker vimentin, tumor 
marker p53, and metastatic marker nm23 and MMP9 
proteins from the sections of primary GBC and tumor 
xenograft of nude mice were examined using immu-
nohistochemistry SABC method. The sections  (4-μm) 
were dehydrated in xylene and graded ethanol series, 
were added in order with primary antibody (CK7, CK8, 
CK19, E-cadherin, vimentin, p53, nm23 or MMP9; all 
1:100, rabbit monoclonal antibody), biotinylated second-
ary antibody, SABC reagents and DAB solution (all from 
Santa Cruz, USA), respectively; i.e., the samples were 
stained with Santa Cruz ABC kit according to the proto-
col provided by the manufacturer, and observed under an 
optical microscope (Olympus IX70, Japan) with  ×100–
400 objectives. Light brown or tan particles in cytoplast 
were regarded as positive. For negative control, the slides 
were treated with PBS in place of primary antibody.
Statistical analysis
All data were expressed as mean  ±  SD and analyzed 
using SPSS (22.0 version software, IBM, USA). Statistical 
analyses to determine significance were tested with Stu-
dent’s t test and F test. P < 0.05 was considered statisti-
cally significant.
Results
A novel GBC cell line, TJ‑GBC2
This present study, a cell line was in  vitro successfully 
established from a primary tumor, which was derived 
from a surgically resected specimen of primary GBC, 
using primary culture of tissue fragment and differential 
adherent purified method; and the cell line was success-
fully frozen, resuscitated and cultured in DMEM/F12 
medium supplemented with 10–20% FBS for >60 genera-
tions. In June 1999, our Tongji University established first 
human GBC cell line SGC-996, which was derived from 
primary GBC. Thus, this novel GBC cell line is currently 
denominated as TJ-GBC2 (Tongji Hospital, Tongji Uni-
versity School of Medicine; Gallbladder Cancer-2).
Epithelial tumor morphological characteristics of TJ‑GBC2 
cell line
Here, the epithelial tumor morphological characteristics 
of the TJ-GBC2 cells in  vitro and the xenograft of TJ-
GBC2 in nude mice in vivo were observed, and compared 
with the morphological characteristic of primary GBC. 
As showed in Fig. 1, TJ-GBC2 cells (the passage 35 and 
50) grew mainly in clusters of polygonal cells, partially 
fusiform, spindly or irregular shape as an adherent mon-
olayer sheet with characteristic epithelial cell morphol-
ogy, in addition to big nucleoplasm ratio and multiple 
nucleoli (Fig. 1a). Moreover, karyomegaly, dicaryon, and 
clear cellular organelle structures such as abundant ribo-
some, mitochondria, prosperous endoplasmic reticulum, 
Golgi apparatus and secretory granules in cytoplasm, 
lots of microvilli outside the network and cell junctions 
between tumor cells (Fig. 1b), and the divided cell and its 
surface full of densely filamentous microvilli and lamellar 
prominences (Fig. 1c) in accord with epithelial cell mor-
phology were clearly visualized under a TEM or SEM. 
Furthermore, in  vivo xenograft in nude mice presented 
typical GBC features in nest-streak like arrangement 
with atypical hyperplasia, caryokinesis and poor differen-
tiation e.g. most of mucous epidermoid carcinoma differ-
entiation, which were consistent with primary tumor of 
GBC (Fig. 1d).
Growth characteristics of TJ‑GBC2 cell line in vitro 
and in vivo
Growth characteristics of TJ-GBC2 cell line composed 
of the proliferation-related properties including prolif-
eration capability, cell cycle and karyotype of TJ-GBC2 
cells in vitro and the tumor growth of xenograft e.g. het-
erotransplantation in vivo. The proliferation capability of 
TJ-GBC2 cells was assayed using the MTT method. Cell 
growth curve of TJ-GBC2 cell line was showed in Fig. 2a, 
i.e. TJ-GBC2 cell line has a less vigorous growth tendency 
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compared to SGC996 in  vitro. Moreover, the cell cycle 
of TJ-GBC2 cell line analyzed using FCM was found 
that about 25% of the cells were in the S-G2/M phase 
(Fig.  2b). Further, complicated karyotype and abnormal 
chromosome number of TJ-GBC2 cell line was revealed 
using chromosome analysis, which included gains, losses, 
translocations and other abnormalities of karyotype; and 
the number of chromosomes ranged between from 52 
to 132, with a peak number between 90 and 105, 80% of 
which is hypertetraploid (Fig.  2c). Furthermore, tumor 
growth of xenograft in  vivo was observed. 2–4  weeks 
after TJ-GBC2 cells were injected subcutaneously into 
the right flanks of nude mice, a visible subcutaneous 
xenograft with a slight slower growth rate was found; at 
8  weeks, xenograft at diameter of range 0.4  cm–0.5  cm 
were observed in all (8/8, 100%) mice.
Epithelial tumor characteristics of TJ‑GBC2 cell line
In order to testify whether TJ-GBC2 cell line has epithe-
lial tumor characteristics, we further detected epithelial 
tumor markers of the culture supernatant of TJ-GBC2 
cells in vitro and characteristic epithelial and mesenchy-
mal cell markers of the xenografts in vivo, and compared 
these markers with primary GBC expressed markers. 
As showed in Fig.  3a, epithelial tumor marker CA19-9 
(>1000 vs. 2.86 U/ml, normal value: <39 U/ml) and AFP 
(65.85 vs. 0.20 ng/ml, normal value: <4.7 n/ml) levels in 
the culture supernatant were higher than those of pure 
growth medium (all P = 0.000); but CEA showed normal 
levels (0.61 vs. 0.61 ng/ml, P > 0.05; normal value: <7 ng/
ml). Characteristic epithelial marker CK7, CK8, CK19 
and E-cadherin were positively expressed in the xeno-
grafts of nude mice, with positive p53 expression in few 
cells and negative mesenchymal marker vimentin expres-
sion (Fig.  3b), which is in accord with the results of 
primary tumor. Took together, these results verified TJ-
GBC2 is an epithelial tumor original cell line.
Highly aggressive characteristic of TJ‑GBC2 cell line
In order to identify the aggressive capability of TJ-GBC2 
cell line, the invasion and migration assays for TJ-GBC2 
cell line were performed; and, the two GBC cell lines 
Fig. 2 Proliferation‑related characteristics and karyotype of TJ‑GBC2 cell line. a The growth curve of TJ‑GBC2 and SGC996 assayed using a MTT 
method. TJ‑GBC2 cell line has a less vigorous growth tendency compared to SGC996 in vitro. b Cell cycle of TJ‑GBC2 cell line detected by FCM, 
about 25% of the cells were in the S‑G2/M phase. c Karyotype analysis of TJ‑GBC2 cell line at the passage 50 (oil‑immersion lens, ×1000): the num‑
ber of chromosomes ranged from 48 to 132, with a peak number between 90 and 105, 80% of which is hypertetraploid
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derived from primary GBC: GBC-SD and SGC996, and 
two GBC cell lines derived from ascites of GBC patients: 
NOZ and OCUG-1 were selected for positive controls. 
As showed in Fig.  4, the number of TJ-GBC2 cells that 
invaded through the basement membrane, i.e. inva-
sion ability was significantly more than that of SGC996 
(>double cell number/fold, *P  <  0.000); whereas no dif-
ference on the number of invaded cells among NOZ, 
GBC-SD, OCUG-1 and TJ-GBC2 cell lines was observed 
(all P  >  0.05; Fig.  4a, c). Moreover, the migration abil-
ity of GBC cell lines was assayed using a wound-healing 
assay. The result showed that the relative migration rate 
of TJ-GBC2, GBC-SD, NOZ and OCUG-1 cell lines for 
8 and 24 h was significantly higher than that of SGC996 
(*P  <  0.05, #P  <  0.01); of them, TJ-GBC2 cell line had a 
highest migration ability compared to GBC-SD, NOZ 
Fig. 3 High expression of epithelial or epithelial tumor marker of TJ‑GBC2 cell line in vitro and in vivo. a Epithelial tumor markers of the culture 
supernatant of TJ‑GBC2 cells in vitro. Supernatant CA19‑9 (>1000 vs. 2.86 U/ml, normal value: <39 U/ml) and AFP (65.85 vs. 0.20 ng/ml, normal 
value: <4.7 n/ml) levels were higher than those of pure growth medium (all P = 0.000); but CEA showed normal levels (0.61 vs. 0.61 ng/ml, P > 0.05; 
normal value: <7 ng/ml). b Expression of characteristic epithelial and mesenchymal cell markers in the xenografts of nude mice in vivo. Epithelial 
marker CK7, CK8, CK19 and E‑cadherin were positively expressed in the xenografts, with positive p53 expression in few cells and negative mesen‑
chymal marker vimentin expression, which is in accord with the results of primary tumor of human GBC
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and OCUG-1 cell lines (all ¶P < 0.01; Fig. 4b, d), and after 
24 h in TJ-GBC2 cell line group the scratched wound of 
the cells completely healed. In order to verify the aggres-
sive and metastatic capabilities of TJ-GBC2 cell line, we 
further examined the expression of metastatic-related 
marker MMP9 and nm23 in the xenograft of nude mice. 
The result showed that MMP9 and nm23 were all strong 
positively stained in xenograft of nude mice, which is 
consistent with result of primary human GBCs (Fig. 4e). 
Therefore, TJ-GBC2 cell line was identified as a highly 
aggressive GBC cell line.
Discussion
Human GBC is a highly aggressive malignant tumor with 
special biological behavior and poor prognosis. Surgi-
cal resection, chemotherapy and radiotherapy for the 
disease are disappointing [1–6]. So, the development of 
novel adjuvant therapies, potential anticancer agents or 
molecularly targeted therapeutics for human GBC on the 
base of comprehensive investigating the biological behav-
iors and metastatic mechanism are very necessary; and 
novel GBC cell lines which were used as ideal experimen-
tal models in vitro and in vivo are urgently developed. In 
present study, we firstly established a novel highly aggres-
sive GBC cell line derived from primary tumor, TJ-GBC2.
Human GBC cell lines are relatively scarce. Nowa-
days, more than a dozen of GBC cell lines were avail-
able, including G-415, GBK-1, KMG-A, FU-GBC-1, 
FU-GBC-2, NOZ, PTHrP-GBK, GB-d1, TGBC1TKB, 
TGBC2TKB, OCUG-1, TYGBK-1, HAG-1, GBC-SD, 
SGC-996, EH-GB1 and EH-GB2 [8–24]. Of these, most 
were derived from the metastatic lesions of GBC patients, 
such as NOZ, OCUG-1, FU-GBC-2 and EH-GB1 from 
the ascites or the abdominal wall [11, 13, 21], TYGBK-1 
from a lymph node [24], and EH-GB2 from liver meta-
static site [23]; some were derived from primitive cul-
tured tumor that planted in nude mice [18]; whereas 
others had themselves features, for example, GBK-1 was 
derived from human colony stimulating factor-producing 
GBC [9], KMG-A from AFP-producing GBC [10], and 
PTHrP-GBK from parathyroid hormone-related peptide 
producing GBC [16]. Indeed, it is much more difficult to 
generate a primary cultured GBC cell line from a primary 
tumor than from metastases and ascites. This is because 
there are more fibrous tissues in GBC lesions, and biliary 
obstruction and infection contaminated GBC specimens. 
It is well known that the cell lines derived from ascites or 
other metastatic sites, or primitive cultured xenograft in 
nude mice were at least limited in two respects: one limi-
tation was these cell lines derived from metastatic site 
losing the properties possessed in primary tumor, and 
cell line monoclonality that could not reflect heterogenic 
properties of the pleomorphic type of GBC; another 
limitation was these cell lines derived from xenografts of 
nude mice with a part of the immune function still hav-
ing stronger immune-resistance. Therefore, culture of 
primary tumor of GBC may be a better way to build a 
cell line so as to accurately reflect the characteristics of 
the primary tumor cells [26]. In present study, we suc-
cessfully established a novel GBC cell line (TJ-GBC2) 
from a Chinese patient with primary GBC, with retain-
ing characteristic epithelial tumor morphology and phe-
notypic in consistent with primary GBC. Although the 
cell line appears to have no prominent capacities of pro-
liferation and growth in  vitro and in  vivo, chromosome 
analysis presented abnormity in structure and number 
of chromosome, and most cells (about 80%) were hyper-
tetraploid, which implied high malignant potential. Coex-
istence of polygon, fusiform, irregular shape cells further 
implied that the cell line was derived from multicenter 
or polyclone. Therefore, primary cultured TJ-GBC2 cell 
line derived from primary tumor of GBC may reflect 
more accurately the characteristics of the primary GBC 
cells. TJ-GBC2 cell line proved to be an efficient tool for 
further investigation of the metastatic mechanism and 
potential targeted therapy of human GBC.
Epithelial tumor characteristics include epithelial 
morphological features, positive expression of epithelial 
markers with negative mesenchymal expression, and pos-
itive expression of epithelial tumor markers. As showed 
in Figs. 1 and 3, TJ-GBC2 cell line has characteristic epi-
thelial tumor phenotypes as well as above characteristic 
epithelial tumor morphology in consistent with primary 
GBC. As we know, CK7, CK8, CK19 and E-cadherin 
are special epithelial markers; vimentin is characteris-
tic mesenchymal marker; whereas CA19-9 and AFP are 
(See figure on previous page.) 
Fig. 4 The highly aggressive characteristic of TJ‑GBC2 cell line. a, c The invasion capability of five GBC cell lines in vitro (Transwell invasion assay; 
Giemsa stain, ×200). The number of TJ‑GBC2 cells that invaded through the basement membrane was significantly more than that of SGC996 
(*P < 0.000), without difference on the number of invaded cells among NOZ, GBC‑SD, OCUG‑1, TJ‑GBC2 cell lines (all P > 0.05). b, d The migration 
capability of five GBC cell lines in vitro (Wound healing assay). The migration rate of TJ‑GBC2, GBC‑SD, NOZ and OCUG‑1 cell lines was significantly 
stronger than that of SGC996 (*P < 0.001, #P < 0.001); of them, TJ‑GBC2 cell line had a strongest migration ability compared to GBC‑SD, NOZ and 
OCUG‑1 cell lines (all ¶P < 0.01). e The expression of metastatic‑related marker MMP9 and nm23 protein in the xenograft of nude mice and primary 
tumor of human GBC. MMP9 and nm23 protein was positively expressed in the xenograft of nude mice, which is consistent with the result of 
primary tumor of human GBC
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epithelial tumor markers. Electrochemistry luminescence 
immunity analysis showed that levels of CA19-9 and AFP 
were significantly increased in the culture supernatant 
of TJ-GBC2 cells; that CK7, CK8, CK19 and E-cadherin 
proteins were positively expressed in the xenograft of 
nude mice, with negative expression of mesenchymal 
marker vimentin, which is in accord with the results of 
primary tumor. These results verified TJ-GBC2 is an epi-
thelial original cell line.
Metastasis, the spread of malignant cells from a pri-
mary tumor to distant sites and forms a tumor of same 
nature [27, 28], is the biggest problem to cancer treat-
ment [29]. Abilities of migration and aggression affect 
the invasion and metastasis of tumor cells to a large 
extent. Intractability of gallbladder cancer also attrib-
ute to its early invasion and metastasis. In present study, 
we detected the aggressive and migration capabilities of 
five GBC cell lines, and expression of metastatic-related 
marker nm23 and MMP9 in the xenograft of TJ-GBC2 
cell lines in nude mice. The results showed that TJ-GBC2 
cell line had higher invasion ability and the highest migra-
tion ability compared to other human GBC cell lines such 
as GBC-SD and NOZ; and that MMP9 and nm23 were 
positively expressed in xenograft of nude mice, which is 
consistent with result of primary tumor of human GBCs. 
It was reported that GBC-SD is so far a human GBC cell 
line having the highest aggressive capability, which was 
derived from primary GBC [15, 20, 22]; whereas NOZ 
is a human GBC cell line having the highest aggressive 
capability, which was derived from metastatic site of 
primary GBC [11, 30]. In this study, cells that invaded 
through the basement membrane for 24  h having more 
than double cell number/fold in invasive assay and cells 
that were in a wound healing experiment for 24 h having 
completely healed cell wound were was used to defined 
as highly aggressive cell line. Considering GBC-SD and 
NOZ as the highest aggressive capability GBC cell lines, 
TJ-GBC2 cell line having a higher invasion ability and the 
highest migration ability compared to GBC-SD, NOZ, 
OCUG-1 and SGC-996, and positive expression of met-
astatic-related marker MMP9 and nm23 in the xenograft 
of TJ-GBC2 cells in nude mice, which is consistent with 
result of primary GBC, we thus identified TJ-GBC2 as a 
highly aggressive GBC cell line.
Conclusions
Collectively, in this study, we firstly established a novel 
highly aggressive TJ-GBC2 cell line derived from a Chi-
nese patient with primary GBC. This GBC cell line has 
characteristic epithelial tumor morphology and phe-
notypes in consistent with primary GBC and highly 
aggressive potential, and reflects more accurately the 
characteristics of the primary GBC cells. Thus, TJ-GBC2 
cell line may provide an efficient tool for further inves-
tigating the metastasis mechanism, early diagnosis and 
potential targeted therapy of human GBC.
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